Markus Markus Stücker

Prof. Dr. Markus Markus Stücker

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
MSMarkus Markus Stücker
Markus Markus Stücker
ASA. Struk
A. Struk
PAP. Altmeyer
P. Altmeyer
MHM. Herde
M. Herde
HBH. Baumgärtl
H. Baumgärtl
DLD. W. Lübbers
D. W. Lübbers
It has been known since 1851 that atmospheric oxygen is taken up by the human epidermis. The contribution to total respiration is negligible. Until now the significance for the local oxygen supply of the skin has remained unknown. With a newly developed sensor, the oxygen fluxoptode, it has become possible to make local measurements of the transcutaneous oxygen flux (tcJO2). In this study the sensor was calibrated so that absolute values of tcJO2 could be reported. At rest, tcJO2 was determined on normal, humidified skin on the volar forearm of 20 volunteers of different age groups. In order to evaluate the contribution of the blood flow to the oxygen supply of the skin, tcJO2 was recorded at the end of a 5 min suprasystolic occlusion of the forearm. At normal skin surface partial oxygen pressure (163 ± 9 Torr), tcJO2 was 0.53 ± 0.27 ml O2 min−1 m−2. A 5 min interruption of blood flow resulted in an increase of 9.5 ± 6.3 % in tcJO2. The value of tcJO2 was unaffected by the age of the subject. Published data on the oxygen diffusion properties of skin and simulations of intracutaneous profiles of oxygen partial pressure indicated that under these conditions, the upper skin layers to a depth of of 0.25–0.40 mm are almost exclusively supplied by external oxygen, whereas the oxygen transport of the blood has a minor influence. As a consequence, a malfunction in capillary oxygen transport cannot be the initiator of the development of superficial skin defects such as those observed in chronic venous incompetence and peripheral arterial occlusive disease.

27 August 2024 in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verified
Journal Article
Open access
GFGabriele Faerber
Gabriele Faerber
MCManuel Cornely
Manuel Cornely
CDConstance Daubert
Constance Daubert
GEGabriele Erbacher
Gabriele Erbacher
JFJodok Fink
Jodok Fink
Erich BrennerErich Brenner
Erich Brenner
Summary: This S2k guideline was developed on the initiative and under the German Society of Phlebology and Lymphology (DGPL) leadership. The guideline aims to optimize the diagnosis and treatment of lipedema. It is intended to bring together the different approaches of the respective professional groups in a consensus‐based manner and thus offer a basic concept for the best possible treatment of patients with lipedema. Sixty recommendations were formulated and agreed on in diagnostics, conservative and surgical treatment options, psychosocial factors and self‐management. The guideline is intended to reflect the current scientific knowledge and be widely used for diagnosis and treatment recommendations for patients with lipedema.In particular, the guideline comments on diagnostic criteria, differential diagnoses, and coinciding clinical pictures, their influence on diagnosis and treatment, sensible treatment measures, and self‐management options. The lipedema guideline summarizes the current national and international evidence and the German expert consensus and derives recommendations for the best treatment for patients with lipedema. The recommendations in the guideline are intended as an orientation aid in the sense of action and decision‐making corridors from which deviations are possible in justified cases.

4 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Nessr Abu RachedNessr Abu Rached
Nessr Abu Rached
Suse KleySuse Kley
Suse Kley
MSMartin Storck
Martin Storck
TMThomas Meyer
Thomas Meyer
MSMarkus Markus Stücker
Markus Markus Stücker
Chronic wounds (CWs) pose a significant health challenge in clinical practice. Standard wound therapy (SWT) is currently considered the gold standard. However, recent evidence suggests that cold plasma therapy (CPT) holds promise for improving CWs. In light of this, the POWER study was conducted as a multicenter, randomized clinical trial to investigate the effect of large-area plasma application compared with SWT in patients with chronic, non-healing arterial or venous wounds on the lower leg. To analyze the interim results, we employed a comprehensive range of statistical tests, including both parametric and non-parametric methods, as well as GLS model regression and an ordinal mixed model. Our findings clearly demonstrate that CPT therapy significantly accelerates wound closure compared with SWT. In fact, complete wound closure was exclusively observed in the CPT group during the intervention period. Additionally, the CPT group required significantly less antibiotic therapy (4%) compared with the SWT group (23%). Furthermore, CPT led to a significant reduction in wound pain and improved quality of life compared with SWT. In conclusion, the study highlights that the combination of CPT and SWT surpasses monotherapy with SWT alone.

17 May 2004 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
MSMarkus Markus Stücker
Markus Markus Stücker
CPC. Pieck
C. Pieck
CSC. Stoerb
C. Stoerb
RNR. Niedner
R. Niedner
JHJ. Hartung
J. Hartung
PAP. Altmeyer
P. Altmeyer

1 April 2004 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
MSMarkus Markus Stücker
Markus Markus Stücker
KNKatharina Netz
Katharina Netz
FBFrank Breuckmann
Frank Breuckmann
PAPeter Altmeyer
Peter Altmeyer
AMAchim Mumme
Achim Mumme

13 January 2010 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
EREberhard Rabe
Eberhard Rabe
MSMarkus Markus Stücker
Markus Markus Stücker
BOBertram Ottillinger
Bertram Ottillinger
Water displacement leg volumetry is a highly reproducible method, allowing the confirmation of efficacy of vasoactive substances. Nevertheless errors of its execution and the selection of unsuitable patients are likely to negatively affect the outcome of clinical studies in chronic venous insufficiency (CVI).